Trigeminal neuralgia is a sudden, severe facial pain, described as sharp, shooting or like an electric shock.It usually occurs in sudden short attacks lasting from a few seconds to about two minutes, which stop just as abruptly. In the vast majority of cases it affects part or all of one side of the face, with the pain most commonly felt in the lower part of the face. Very occasionally it affects both sides of the face, but not normally at the same time. Part of the controversy that surrounds the pathophysiology of TGN is based on misquotations and inaccuracies. Against popular belief, sensory impairment in TGN—albeit small—has been documented by several groups, both using quantitative sensory testing and neurophysiological methods. As already mentioned, these changes normalize following successful MVD. Transcranial magnetic stimulation appears promising, but results are still scarce. Adjunct treatments such as mechanical, electrical, and thermal stimuli sometimes modify pain with fewer adverse effects than medication. Self-adhesive bandages may also be used. Sweden people around 26,841 among the total population are suffering from this disease that is 1.38% of the population effected.